Diabetomics India Private Limited

Provides support services for diabetes, endocrinology, and metabolism clinical trials in India and abroad.

2008 | Hyderabad, Telangana (India) | Inactive
Last Updated: November 16, 2024

Diabetomics India Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 17 Year, 6 Days
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth -845.66%
  • Total Assets %

About Diabetomics India

Diabetomics India Private Limited (DIPL) is Strike Off company established on 07 Feb 2008 with its office registered at Hyderabad, Telangana, India and has been running since 17 Year, 6 Days with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 16 Nov 2024.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U85195TG2008PTC057483

  • Company No.

    057483

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    07 Feb 2008

  • Date of AGM

    26 Jun 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Healthcare

Who are the key members and board of directors at Diabetomics India?

Board Members (2)

Name Designation Appointment Date Status
Paturi Ushabala Country flag representing In Director 07-Feb-2008 Current
Ramachandra Rao Country flag representing In Additional Director 15-Mar-2018 Current

Financial Performance of Diabetomics India.

Diabetomics India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 845.66% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
-845.66%
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Diabetomics India?

In 2023, Diabetomics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Diabetomics India?

Unlock and access historical data on people associated with Diabetomics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Diabetomics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diabetomics India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Diabetomics India

Recent activity within the organization

  • Annual General Meeting

    Diabetomics India Private Limited last Annual general meeting of members was held on 26 Jun 2023 as per latest MCA records.

    26 Jun 2023

  • Balance Sheet

    Diabetomics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

    31 Mar 2023

  • Director Appointment

    Ramachandra Maddipati Rao was appointed as a Additional Director was appointed as a Additional Director on 15 Mar 2018 & has been associated with this company since 6 years 11 months .

    15 Mar 2018

  • Director Appointment

    Paturi Ushabala was appointed as a Director was appointed as a Director on 07 Feb 2008 & has been associated with this company since 17 years 6 days .

    07 Feb 2008

  • Company Incorporation

    Diabetomics India Private Limited was registered on 07 Feb 2008 with Roc Hyderabad & aged 17 years 6 days as per MCA records.

    07 Feb 2008

Frequently asked questions

  • Diabetomics India Private Limited was incorporated on 07 Feb 2008.

  • The authorized share capital of Diabetomics India Private Limited is ₹ 5.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Diabetomics India Private Limited.

    • Paturi Ushabala
    • Ramachandra Maddipati Rao
  • As per Ministry of Corporate Affairs (Mca), the registered address of Diabetomics India Private Limited is H. No: 6-3-349/17/B Hindi Nagar Behind Punjagutta Sai Baba Temple, Banja Ra Hills India, Hyderabad, Telangana, 500034.

  • The corporate identification number (CIN) of Diabetomics India Private Limited is U85195TG2008PTC057483 and the company number is 057483 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Diabetomics India Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Preventive Health Services